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Disorders of mitochondrial DNA (mtDNA) maintenance are clinically and genetically heterogeneous, embracing recessive mtDNA
depletion syndromes aﬀecting children and adult-onset multiple mtDNA deletion disorders. Here we show that mutation of MPV17 – a
gene implicated in severe, infantile hepatocerebral mtDNA depletion disorders characterised by a loss of mtDNA copies – can also cause
clonally-expanded mtDNA deletion and focal cytochrome c oxidase (COX) deﬁciency in skeletal muscle associated with an adult
presentation of neuropathy and leukoencephalopathy. The mpv17 protein is therefore intimately involved in both the mtDNA
replication and repair processes and associated with both quantitative and qualitative mtDNA abnormalities.
 2012 Elsevier B.V.
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Mitochondrial respiratory chain diseases embrace a clin-
ically and genetically heterogeneous group of inherited
human disorders in which neurological involvement is
prominent. These can be due to either mitochondrial
DNA (mtDNA) mutations, or one of an increasing number
of Mendelian disorders in which the primary genetic defect
has a secondary consequence on mtDNA stability, result-
ing in defective nuclear–mitochondrial intergenomic com-
munication [1,2]. This secondary mtDNA defect is
expressed in one of two forms: mtDNA depletion syn-
dromes are characterised by a quantitative loss of mtDNA
copy number, leading to isolated organ or multi-systemic
paediatric disease, and have been described in association
with recessive mutations in at least nine genes – POLG,0960-8966 2012 Elsevier B.V.
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Open access under CC BY license.PEO1, DGUOK, TK2, RRM2B, TYMP, MPV17,
SUCLA2 and SUCLG1 [3]. With the exception of
MPV17, all gene products are involved in either mitochon-
drial DNA replication/repair or the maintenance of mito-
chondrial deoxyribonucleotide pools; mutations in
MPV17 are associated with hepatocerebral mtDNA deple-
tion but the function of the mpv17 protein remains uncer-
tain [4]. Alternatively, the secondary mtDNA defect can
manifest as an accumulation of clonally-expanded mtDNA
deletions in skeletal muscle, leading to an associated respi-
ratory chain defect which is often demonstrated as a
mosaic pattern of cytochrome c oxidase (COX)-deﬁcient
cells and associated with later onset of clinical symptoms
in adult life.
To date, mutations in just four of these genes – POLG,
PEO1, RRM2B and recently TK2 – have been described as
causes of both infantile mtDNA depletion syndromes and
adult-onset, multiple mtDNA deletion disorders [5–12].
We describe a patient presenting with a severe peripheral
neuropathy, leukoencephalopathy and liver involvement
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multiple mtDNA deletions and focal COX deﬁciency in
skeletal muscle.Fig. 1. MRI ﬁndings. Cranial MRI demonstrates conﬂuent high signal
(arrows) in white matter of the frontal and parietal lobes in axial (a, T2
weighted) and coronal (b, FLAIR) sequences, suggestive of
leukoencephalopathy.2. Case report and methods
2.1. Case report
The patient is a 21 year-old Pakistani male, born to non-
consanguineous parents. He was diagnosed with Hepatitis
A (IgM positive) at the age of 3 years and made a full
and uneventful recovery. He ﬁrst developed neurological
symptoms at age 14 years, with gradual onset of walking
diﬃculties that progressed over several years to bilateral
foot drops requiring orthoses. Over the same period he also
developed symmetrical distal numbness and subjective
coldness in both feet ascending to the knees, and more
mildly in his hands. There was no signiﬁcant cognitive
impairment.
Examination revealed muscle wasting of hands and dis-
tal lower limbs. He had clawed toes, but no pes cavus or
nerve thickening. He walked with a slow, unsteady gait.
Tone was decreased and muscle power was severely weak
in a number of distal muscle groups, with no detectable
power (MRC grade 0/5) in left abductor pollicis brevis,
both ﬁrst dorsal interossei and both anterior tibialis mus-
cles. While proximal power was normal in the upper limbs,
there was symmetrical weakness (MRC grade 4-/5) of hip
ﬂexion. All tendon reﬂexes were absent. Sensory examina-
tion was normal in the upper limbs, but revealed decreased
perception of pin-prick and light touch distal to the knees,
impaired vibration sense to the ankles and absent joint
position sense at the toes. There was mild hepatomegaly.
Liver ultrasound revealed abnormal echogenicity, serum
liver enzymes were minimally abnormal (gamma GT
70 U/L, normal range <55 U/L), CT showed heterogeneous
liver enhancement, and liver biopsy conﬁrmed patchy stea-
tosis (20%) with early bridging ﬁbrosis, but overall
clinically there was no signiﬁcant chronic liver disease.
CSF analysis showed an increased protein of 1963 mg/L
(normal <500 mg/L) and raised lactate of 4.3 mmol/L
(normal 0.7–2.0 mmol/L). Cranial MRI revealed diﬀuse
hyperintense T2 weighted signal in the cerebral white matter
(Fig. 1) and cerebellum, but imaging of the brain stem was
normal. A previous MRI head scan at age 9 years,
performed because of headaches, was normal. Nerve con-
duction studies conﬁrmed an axonal sensory motor poly-
neuropathy and sural nerve biopsy showed a severe
chronic axonal neuropathy with only occasional surviving
myelinated axons.
The patient’s sister developed a progressive, fatal hepa-
titis at age 9 years. Their father had suﬀered an episode of
hepatitis as a child but made a full recovery. The patient’s
mother and older brother are both well and there are no
other family members with either liver disease or
neuropathy.2.2. Muscle biopsy and mitochondrial DNA analysis
Left quadriceps needle muscle biopsy was performed
with informed consent. Histological and histochemical
analyses of mitochondrial enzyme activities, including the
sequential reaction for COX and succinate dehydrogenase
(SDH) activities, were performed using 10 lm serial
cross-sections according to standard procedures [13] as
was electron microscopy (EM). This study had the relevant
institutional ethical approval and complied with the Decla-
ration of Helsinki.
Total DNA was extracted from the muscle biopsy by
standard procedures and screened for common mtDNA
point mutations. A long-range PCR assay employing a pair
of primers (L3965 (nucleotides 3965–3984) and H129
(nucleotides 129–110)) ampliﬁed a 12.7 kb product in
wild-type mtDNA across the major arc of mtDNA to
screen for mtDNA rearrangements (GenBank Accession
No. NC_012920.1). The level of deleted mtDNA in individ-
ual COX-deﬁcient and COX-positive reacting muscle ﬁbres
was determined by quantitative real-time PCR of the
MTND1 and MTND4 regions of the mitochondrial gen-
ome as previously described [14]. In addition, the assess-
ment of mtDNA copy number in the patient’s muscle
sample was investigated by a real-time PCR assay, which
co-ampliﬁes a mtDNA-encoded gene (MTND1) and a
nuclear housekeeping gene (18S rRNA) [15].2.3. Nuclear genetic analysis
The entire coding regions, including intron–exon bound-
aries, of the POLG (NM_002693), DGUOK (NM_080918)
and MPV17 (NM_002437.4) genes were ampliﬁed using
intronic M13-tailed primers by standard PCR. Puriﬁed
PCR products (ExoSapIT, GE Healthcare) were sequenced
with BigDye Terminator cycle sequencing chemistries on
an ABI3130xl Genetic Analyzer (Applied Biosystems)
and analysed using Mutation Surveyor software
(Softgenetics).
Fig. 2. Muscle biopsy ﬁndings. (a) H&E, scale bar = 100 lm and (b) Gomori trichrome, scale bar = 50 lm reveal evidence of subsarcolemmal
mitochondrial accumulation consistent with “ragged-red” changes in the patient’s biopsy. (c) Several ﬁbres are depleted for COX activity (asterisked; scale
bar = 100 lm), which is accentuated following the histochemical demonstration of sequential COX and SDH activities (d; scale bar = 250 lm). (e)
Electron microscopy revealed focal subsarcolemmal accumulation of abnormal mitochondria in muscle with typical parking lot-like inclusions, scale
bar = 500 nm.
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H&E staining of the muscle biopsy was generally unre-
markable, revealing only scattered small ﬁbres; there was
no evidence of necrosis, phagocytosis, inclusions, ﬁbre
splitting or inﬂammatory inﬁltrate although occasional
ﬁbres displayed internal nucleation (Fig. 2a). Modiﬁed
Gomori trichrome staining identiﬁed accumulation of
mitochondria, consistent with a total of four ragged-red
ﬁbres representing 1% of the total biopsy (Fig. 2b) whilst
COX reactivity revealed a number of pale ﬁbres (Fig. 2c).
Signiﬁcant mitochondrial respiratory chain deﬁciency was
conﬁrmed following sequential COX–SDH histochemistry
which identiﬁed 20% COX-deﬁcient ﬁbres throughout
the biopsy, implicating mtDNA involvement (Fig. 2d).
Electron microscopy demonstrated focal subsarcolemmal
accumulation of abnormal mitochondria with typical park-
ing lot-like inclusions in some of the enlarged mitochondria
(Fig. 2e).
Real-time PCR demonstrated a normal mtDNA copy
number in muscle, whilst commonmtDNA point mutations
were excluded. Long-range PCR ampliﬁcation showed the
presence of multiple mtDNA deletions (Fig. 3a), conﬁrming
a disorder of mtDNA maintenance. Real-time PCR of indi-
vidual, laser-captured COX-deﬁcient ﬁbres also failed to
identify a mtDNA copy number abnormality but clearly
revealed that a proportion of ﬁbres had high levels of clon-
ally-expanded mtDNA deletion involving theMTND4 gene
(Fig. 3b), a consistent observation in patients with diﬀerent
nuclear-driven, multiple mtDNA deletion disorders.
Sequencing of three genes (POLG,DGUOK andMPV17)
implicated inmtDNAmaintenance disorders with hepatoce-
rebral involvement revealed a homozygous missense variant
(c.2898C>T; p.Pro98Leu) in MPV17 which has previously
been reported as a recessive mutation associated with
mtDNA depletion in liver (Fig. 3c), aﬀecting a highly con-
served amino acid within the mpv17 protein (Fig. 3d) [16].4. Discussion
The intra-mitochondrial processes of synthesizing and
maintaining mtDNA are dependent not only on a balanced
supply of nucleotides, but also on the integrity and con-
certed action of the mtDNA replication machinery. Dis-
ruption of either process can lead to either depletion or
deletion of mtDNA, but the factors governing which of
these pathological processes prevails are unclear.
Previously, a p.Arg50Gln ‘founder’ mutation inMPV17
has been associated with Navajo neurohepatopathy (NNH;
MIM 256810), a disorder aﬀecting Native American
Navajo children, who present with liver disease, failure to
thrive, recurrent metabolic acidosis at times of intercurrent
infection, corneal scarring, severe sensory and motor nerve
impairment and cerebral leukoencephalopathy [17]. Three
overlapping phenotypes of NNH have been described with
an inverse correlation between age of onset and disease
severity. Infantile NNH is an early onset, fatal form of
hepatocerebral depletion syndrome while the mildest (clas-
sic) form of NNH is characterised by moderate liver dys-
function and progressive demyelination aﬀecting
peripheral and central nerve axons. Depletion of mtDNA
has been conﬁrmed in liver biopsies [17], but skeletal mus-
cle involvement has not been documented in these patients,
or in those patients with other MPV17 mutations and
hepatocerebral depletion syndrome [4,18–20].
The case we present, although phenotypically similar to
the classic form of NNH, is unusual in several respects.
Importantly, histochemical analysis demonstrated clear
evidence of muscle involvement with ragged red ﬁbres
and a mosaic pattern of COX deﬁciency. The latter impli-
cated mtDNA in the pathogenetic mechanism of disease in
this patient, but rather than depletion of mtDNA, we iden-
tiﬁed multiple mtDNA deletions in skeletal muscle, a ﬁnd-
ing not previously noted in patients with MPV17
mutations.
Fig. 3. MPV17 mutation causes multiple mtDNA deletions. (a) Long range PCR of muscle DNA shows signiﬁcant evidence of multiple mtDNA
deletions. Lane 1, DNA size marker; lane 2, patient; lane 3, age-matched control. (b) Quantitative, single ﬁbre real-time-PCR showing many COX-
deﬁcient ﬁbres containing high levels of a clonally-expanded mtDNA deletion involving the MTND4 gene. (c) Sequence chromatogram highlighting the
c.298C>T (p.Pro98Leu)MPV17mutation identiﬁed in our patient. (d) Amino acid alignments of the mpv17 protein from diﬀerent species conﬁrms a strict
conservation of p.Pro98 throughout species from human to yeast.
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were from the same Asian ethnicity and the presence of a
homozygous p.Pro98Leu mutation [16] suggests that the
parents shared a common ancestor or that this recessive
mutation has high population prevalence in this Asian
group. Given the experience with NNH, it would seem that
a shared common ancestor or founder is most likely; unfor-
tunately, parental samples were not available to conﬁrm
carrier status.
The mpv17 protein is an inner mitochondrial membrane
comprising four transmembrane domains yet its function
and role in the pathogenesis of autosomal recessive disor-
ders of mtDNA maintenance are far from clear in spite
of studies in disease models. Deletion of SYM1, the yeast
orthologue of the MPV17 gene, causes mitochondrial bio-
energetic defects and mtDNA instability [21] whilst a severe
mtDNA depletion aﬀecting the liver and CNS tissues was
observed in the MPV17/ knockout mouse [22]. Of fur-
ther interest, the mouse model did exhibit evidence of respi-
ratory chain deﬁciency in muscle but this was shown to be
due to mtDNA depletion. Although our report documents
the ﬁrst patient with MPV17 mutation leading to multiple
mtDNA deletions and associated COX abnormalities in
muscle, the clinical and molecular ﬁndings in patients with
hepatocerebral mtDNA depletion have recently been sum-
marised to investigate possible phenotype–genotype corre-
lations associated with autosomal recessive MPV17
abnormalities [16]. Mutations are found to be located
throughout the mpv17 protein, in both transmembrane
and extramembrane domains, but interestingly some may
be associated with longer survival and better outcome fol-
lowing liver transplantation; interestingly, these include thep.Arg50Gln NNH mutation and the p.Pro98Leu mutation
as observed in our patient, although this has only been
described in one case previously [16].
In conclusion, we have identiﬁed the presence of clon-
ally-expanded mtDNA deletions in muscle, a tissue not
previously recognised to be involved in the pathological
process of mpv17-related disease. Although the precise
function of this remains undetermined, we conﬁrm this
protein as being intimately involved in both the mtDNA
replication and repair processes and associated with both
quantitative and qualitative mtDNA abnormalities.
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